Intercure Current Valuation vs. Gross Profit
| INCR Stock | ILS 498.20 28.80 5.46% |
For Intercure profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Intercure to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Intercure utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Intercure's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Intercure over time as well as its relative position and ranking within its peers.
Intercure |
Intercure Gross Profit vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Intercure's current stock value. Our valuation model uses many indicators to compare Intercure value to that of its competitors to determine the firm's financial worth. Intercure is considered the number one company in current valuation category among its peers. It also is currently regarded as number one stock in gross profit category among its peers fabricating about 0.15 of Gross Profit per Current Valuation. The ratio of Current Valuation to Gross Profit for Intercure is roughly 6.71 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Intercure by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Intercure's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Intercure Current Valuation vs. Competition
Intercure is considered the number one company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about (5.37 Billion). Intercure adds roughly 688.06 Million in current valuation claiming only tiny portion of equities under Health Care industry.
Intercure Gross Profit vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Intercure |
| = | 688.06 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Intercure |
| = | 102.56 M |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Intercure Gross Profit Comparison
Intercure is currently under evaluation in gross profit category among its peers.
Intercure Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Intercure, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Intercure will eventually generate negative long term returns. The profitability progress is the general direction of Intercure's change in net profit over the period of time. It can combine multiple indicators of Intercure, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
InterCure Ltd. invests in the biomedical, life sciences, and biotechnology sectors in Israel and internationally. InterCure Ltd. was founded in 1994 and is based in Hadera, Israel. INTERCURE LTD is traded on Tel Aviv Stock Exchange in Israel.
Intercure Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Intercure. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Intercure position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Intercure's important profitability drivers and their relationship over time.
Use Intercure in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Intercure position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intercure will appreciate offsetting losses from the drop in the long position's value.Intercure Pair Trading
Intercure Pair Trading Analysis
The ability to find closely correlated positions to Intercure could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Intercure when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Intercure - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Intercure to buy it.
The correlation of Intercure is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Intercure moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Intercure moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Intercure can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Intercure position
In addition to having Intercure in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cancer Fighters Thematic Idea Now
Cancer Fighters
Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. The Cancer Fighters theme has 60 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cancer Fighters Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Intercure Stock
To fully project Intercure's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Intercure at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Intercure's income statement, its balance sheet, and the statement of cash flows.